| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 05/22/2002 | CN1350587A Acquired resistance genes in plants |
| 05/22/2002 | CN1350581A Method for amplifying nucleic acid sequence |
| 05/22/2002 | CN1350579A 葡萄糖脱氢酶 Glucose dehydrogenase |
| 05/22/2002 | CN1350547A Alleviation of the alelrgenic potential of airborne and contact allergens by thioredoxin |
| 05/22/2002 | CN1350546A 结核诊断测验 TB diagnostic test |
| 05/22/2002 | CN1350542A Xylo-LNA analogues |
| 05/22/2002 | CN1350180A Simple and fast light microscope detection technology for blood and lymph of live shrimp and crab |
| 05/22/2002 | CN1350062A Method of identifying production using gene expression |
| 05/22/2002 | CN1350061A Method of estalishing ApoAI target cell screening medicine system and screening HDL raising medicine |
| 05/22/2002 | CN1085248C Molecular marking method for seedless grape breeding |
| 05/22/2002 | CA2343422A1 Dna profile storage |
| 05/21/2002 | US6392028 Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
| 05/21/2002 | US6392027 Mammalian adrenocorticotropic hormone receptor nucleic acids |
| 05/21/2002 | US6392018 Polypeptides for use in the treatment of pathologies associated with inflammatory respone, nervous system disorders and leukemias; for use as a molecular weight control; for use in foods |
| 05/21/2002 | US6392016 Preferential polypeptide for use in the diagnosis and treatment of tumors; antiproliferative agents |
| 05/21/2002 | US6392015 Organelle targeting protein; for use in treatment of viral disease |
| 05/21/2002 | US6391853 Human tissue inhibitor of metalloproteinase-4 |
| 05/21/2002 | US6391847 Modulating transcription |
| 05/21/2002 | US6391656 Quantitative analysis |
| 05/21/2002 | US6391655 Oxidized styrenic polymers for DNA binding |
| 05/21/2002 | US6391654 Apparatus for the separation of viable semen from nonviable semen |
| 05/21/2002 | US6391645 Method and apparatus for correcting ambient temperature effect in biosensors |
| 05/21/2002 | US6391640 Methods and compositions for cellular and metabolic engineering |
| 05/21/2002 | US6391634 Monoclonal antibodies and their production and use |
| 05/21/2002 | US6391631 Nucleotide sequences for use as tools in genetic engineering and analysis |
| 05/21/2002 | US6391630 Nucleotide sequences for use in the diagnosis, prevention and treatment of cancer |
| 05/21/2002 | US6391626 Nutrient broth for the detection of bacteria |
| 05/21/2002 | US6391625 Biochip and method for patterning and measuring biomaterial of the same |
| 05/21/2002 | US6391624 Apparatus for the detection of prokaryotic or viral nucleotide sequences in sample |
| 05/21/2002 | US6391622 Closed-loop biochemical analyzers |
| 05/21/2002 | US6391613 Motor proteins and methods for their use |
| 05/21/2002 | US6391609 Generation solution containing blood proteins; extract mammalian tissue, separate coagulaton factors, recover purfied blood protein |
| 05/21/2002 | US6391606 Peptides; for use in the develoment of human diagnostic and therapeutic agents |
| 05/21/2002 | US6391601 Transport protein for use in the treatment of cell proliferation defects, cancer, hyperplasias, restenosis, cardiovascular, immune and inflammatory disorders |
| 05/21/2002 | US6391593 Detecting preferential nucleotide sequences; obtain samples, incubate with probes, amplify nucleotide sequences, detect amplified nucleotide sequences |
| 05/21/2002 | US6391592 Preferential accumulation of nucleotide sequences; obtain nucleic acid samples, incubate with polymerase and blocking agent, recover preferential nucleotide sequences |
| 05/21/2002 | US6391586 Nucleotide sequences which codes heterologous polypeptide for use generation of human therapeutics |
| 05/21/2002 | US6391580 Ras proteins |
| 05/21/2002 | US6391579 Nucleotide sequences coding transport protein for use in the treatment of thyroid defects |
| 05/21/2002 | US6391577 Rapid electrochemical assay for antibiotic and cytotoxic drug susceptibility in microorganisms |
| 05/21/2002 | US6391576 Encapsulating sample of microorganism cells in agarose gel particles, incubating in plate cultures, and isolating particles having single cell from group of particles having more than one cell; culturing hard to grow organisms |
| 05/21/2002 | US6391575 Methods for detecting membrane derived caspase activity and modulators thereof |
| 05/21/2002 | US6391574 AFC1 and RCE1: isoprenylated CAAX processing enzymes |
| 05/21/2002 | US6391562 Array of a plurality of particles having probes, respectively, fixed thereon, said probes being capable of binding to different target substances to be examined, respectively |
| 05/21/2002 | US6391561 Introducing crna molecule encoding k+ channel associated protein and and crna encoding kv alpha subunit into host cell and then co-expressing those proteins |
| 05/21/2002 | US6391560 Contacting rna attatched to a solid support with arrays of oligonucleotides to form duplexes, then contacting with rnase (ribonuclease), and measuring kinetics of cleavage; for screening libraries |
| 05/21/2002 | US6391558 Simple, sensitive method by interacting bioreporter molecule attatched to working electrode with target molecule, adding reporter molecule that can be oxidized or reduced on interaction with complex, applying pulses, measuring current |
| 05/21/2002 | US6391557 Using recombinantly expressed mismatch endonuclease from a plant to determine a mutation in the target sequence of a single-stranded polynucleotide which is hybridized to a non-mutated sequence |
| 05/21/2002 | US6391555 Screening by isolating dna from sample and detecting presence of viral nucleic acid sequences; presence indicates increased risk for lung cancer |
| 05/21/2002 | US6391554 Detecting cancerous conditions by assaying for telomerase activity |
| 05/21/2002 | US6391553 Analyzing level of gene expression of epsilon 4 or epsilon 2 alleles of apolipoprotein e; mutation in consensus sequence binding a transcription factor and either increase in epsilon 4 or decrease in epsilon 2 indicate disease |
| 05/21/2002 | US6391552 Enhancing transfection efficiency of vectors by recursive recombination |
| 05/21/2002 | US6391551 Simple, automatable method of determining presence of endogenous target sequence in sample by mixing target sequence hybridized with 3'-labeled probe with enzyme that releases nucleotides from 3'-end, and analyzing for label |
| 05/21/2002 | US6391550 Identification of molecular sequence signatures and methods involving the same |
| 05/21/2002 | US6391549 Detecting paramater in host cell by transfecting cell with plasmid with b-galactosidase or alkaline phosphatase reporter gene under control of inducible promoter, enzymes catalyze reaction causing signal detectable by electrochemical cell |
| 05/21/2002 | US6391548 Simple and efficent method of introducing specific mutations by using two primers, synthesizing dna using linear cyclic amplification where dna may form into a double-strand, then digesting dna using selection enzyme |
| 05/21/2002 | US6391547 Microbial β-glucuronidase genes, gene products and uses thereof |
| 05/21/2002 | US6391546 Performing two assymetric polymeraase chain reactions using different primers, heating and cooling amplification products to obtain partially double-stranded nucleotide sequence, then detecting sequence |
| 05/21/2002 | US6391545 Multiple antibiotic resistance operon assays |
| 05/21/2002 | US6391544 Method for using unequal primer concentrations for generating nucleic acid amplification products |
| 05/21/2002 | US6391543 Screening sample for preferential nucleotide sequences; incubate sample with nucleotide sequences, monitor sample for signal indicating bound nucleotide sequences |
| 05/21/2002 | US6391542 Oligonucleotides of defined nucleotide sequence; antisense agents; viricides; diagnostic probes |
| 05/21/2002 | US6391539 Immunogenic compositions of human papillomavirus |
| 05/21/2002 | US6391311 Polypeptide comprising amino acid sequence at least about 80% identical to specified sequence, which has biological activity of promoting selective growth and/or survival of human umbilical vein endothelial cells in in vitro assay |
| 05/21/2002 | US6391304 Medicinal product capable of inducing protection in feline host against infection with feline immunodeficiency virus, comprising isolated peptide consisting of or containing specified amino acid sequence |
| 05/21/2002 | US6391298 Method of using PON-1 to decrease atheroma formation |
| 05/21/2002 | US6391176 Detection of alcaline isophosphatases by electrophoresis |
| 05/21/2002 | US6390821 Phosphorylation |
| 05/21/2002 | CA2363510A1 Selectivity of nucleic acid diagnostic and micorarray technologies by control of interfacial nucleic acid film chemistry |
| 05/21/2002 | CA2324662A1 Selectivity of nucleic acid diagnostic and microarray technologies by control of nucleic acid density |
| 05/21/2002 | CA2243759C Fluorescence detection assay for homogeneous pcr hybridization systems |
| 05/21/2002 | CA2215745C Human stat4 |
| 05/21/2002 | CA2215310C Substrates for beta-lactamase and uses thereof |
| 05/21/2002 | CA2139847C Probe for diagnosing infectious disease |
| 05/20/2002 | WO2002039947A2 Carrier vectors through an epithelium with tight junctions |
| 05/16/2002 | WO2002039431A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/16/2002 | WO2002039122A2 Methods for the identification and the treatment of cardiovascular disease |
| 05/16/2002 | WO2002039117A1 Methods for the treatment of cellular proliferative disorders |
| 05/16/2002 | WO2002039113A2 Schiff base reductant co-dispense process |
| 05/16/2002 | WO2002039111A1 Supports for hybridization and method of immobilizing hybrid |
| 05/16/2002 | WO2002039082A2 Method and system for visual identification of microorganisms |
| 05/16/2002 | WO2002038812A2 Method in quantitative analysis of gene and protein expression |
| 05/16/2002 | WO2002038811A2 Assay for the detection and quantitation of hemimethylation |
| 05/16/2002 | WO2002038810A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/16/2002 | WO2002038809A1 Method and apparatus for detecting a mutaiton in a nucleic acid fragment in a sample |
| 05/16/2002 | WO2002038808A2 Slide or chip hybridisation unit |
| 05/16/2002 | WO2002038807A1 Method for screening agents capable of treating obesity |
| 05/16/2002 | WO2002038806A2 Detection of nucleic acid polymorphisms |
| 05/16/2002 | WO2002038805A2 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 05/16/2002 | WO2002038803A2 Novel marker for the diagnosis and therapy of tumours |
| 05/16/2002 | WO2002038802A1 Method for rapid typification of microorganisms and set of reagents used |
| 05/16/2002 | WO2002038801A1 Detection of methylated dna molecules |
| 05/16/2002 | WO2002038800A1 Test piece for assaying high density lipoprotein (hdl) cholesterol |
| 05/16/2002 | WO2002038799A2 Detection of proteases and screening for protease inhibitors |
| 05/16/2002 | WO2002038798A1 Method for screening probiotic strains of the genus bifidobacterium |
| 05/16/2002 | WO2002038797A2 Modulators of bruton's tyrosine kinase, their identification and use |
| 05/16/2002 | WO2002038796A2 Methods for determining protease cleavage site motifs |
| 05/16/2002 | WO2002038795A2 Braf35 protein and brca2/braf35 complex and methods of use |
| 05/16/2002 | WO2002038794A2 Cardiovascular disease diagnostic and therapeutic targets |
| 05/16/2002 | WO2002038792A2 Novel method for analysing phenotypic characteristics of human immunodeficiency virus (hiv) |